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Abstract
Background—Patient characteristics associated with adherence to dual method contraceptive
use are not known.
Study Design—Project PROTECT was a 24-month long randomized trial designed to promote
the use of dual methods of contraception using an individualized computer-based intervention or
enhanced standard care counseling intervention. We analyzed 463 women with follow-up data and
examined sustained dual method use (reported at 2+ interviews).
Results—While 32% initiated dual method contraceptive use, only 9% reported sustained use.
Education increased (RRadj = 4.42; 95%CI 1.19-16.42), substance abuse decreased (RRadj = 0.49;
95%CI 0.24-0.97), no contraceptive use at baseline decreased (RRadj = 0.32; 95%CI 0.11-0.92),
and contraceptive stage of change increased (RRadj =5.04; 95%CI 1.09-23.4) adherence to dual
method use.
Conclusion—To effectively prevent sexually transmitted diseases (STIs) and unplanned
pregnancies, dual method use must be consistent and sustained. Future interventions to promote
dual method use should focus on high-risk groups and additional dual method combinations (e.g.,
barrier plus intrauterine devices or implants).
Keywords
Dual methods; adherence; compliance; STD prevention contraception
1. Introduction
Both unintended pregnancies and sexually transmitted infections (STIs) are major public
health concerns in the U.S. and the international community. In the U.S., the majority of
births to young women are unintended [1.2], and these unintended births are associated with
increased risk of poor health outcomes for both mother and child [3]. Moreover, STIs are on
the rise in the U.S. [4]. Untreated STIs can lead to pelvic inflammatory disease, ectopic
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pregnancy, chronic pelvic pain, and tubal factor infertility and may facilitate HIV
transmission.
No one contraceptive method is effective at preventing both unintended pregnancies and
STIs. Dual method contraceptive use, or the use of both a barrier method (e.g., male
condoms) and a method more effective at pregnancy prevention (intrauterine devices,
implants, hormonal methods, and sterilization), has been proposed as one strategy to
effectively prevent both unintended pregnancies and STIs [5-7]. Recent analyses have
shown that if half of all women using effective contraceptive methods (e.g., oral
contraceptives, contraceptive rings, patches, etc.) alone also used condoms, approximately
40% of unplanned pregnancies and abortions would be prevented [8]. This percentage rises
to 80% if all women currently using effective methods alone started to also use condoms [8].
Thus, adding condoms to commonly used hormonal contraceptives will increase
contraceptive effectiveness. In addition, dual-method contraceptive use, when used
consistently, can prevent pregnancy and STIs [9,10]. Winner et al. found that consistent
condom use reduced incident human papillomavirus (HPV) infection by 70% [11].
Currently, between 11% and 38% of U.S. women 35 years of age and younger use dual-
method contraception [12,13].
Few intervention studies have demonstrated acceptance and adherence to dual method use.
We developed and tested an intervention to promote dual contraceptive use in a randomized-
clinical trial. In this trial, while the tailored, individualized intervention promoted initiation
of dual method use, many women were unable to sustain use over time. However,
participants who adhered to dual method use had lower rates unintended pregnancy at 24
months (HRRadj=0.36, 95% CI 0.15, 0.91) [14]. The purpose of this secondary analysis was
to determine whether certain baseline patient demographic and reproductive characteristics
could predict adherence to dual method contraceptive use over 24 months.
2. Materials and methods
A complete description of the methods of Project PROTECT and the primary outcomes of
the trial have been previously published [10,14]. We briefly review the methods of this trial
below, and describe our analytic technique to assess predictors of adherence to dual method
use. The project was reviewed and IRB-approved prior to recruitment.
Eligibility for Project PROTECT included the following: 1) female gender between the ages
of 13 and 35 years; 2) sexually active with a male partner in the past six months; 3) high risk
for unintended pregnancy or STI; and 4) English-speaking. All sexually active women under
25 years of age were considered high risk, and women 25 years and older were included if
they had the following risk factors: 1) history of unintended pregnancy; 2) history of a STI;
3) inconsistent use of contraception; 4) multiple sexual partners; or 5) substance abuse.
Women were excluded if they were pregnant, had a hysterectomy or sterilization, or were
unable to consent.
Participants were randomly assigned to a tailored, individualized intervention based on the
transtheoretical model of behavior change [10,15,16] or to an enhanced standard care
(comparison) group. The intervention group received computer delivered information
sessions tailored for the use of dual-method contraception, while the comparison group
received non-tailored standard care information and advice [10]. All participants were given
a packet of educational information with information on dual method use and a sample
condom.
We collected the following participant information at baseline: demographics, reproductive
history, sexual history, STI history, current and past contraceptive use, substance abuse,
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domestic violence, and levels of stress, and five stages change for contraceptive use. In the
three early stages (Precontemplation, Contemplation and Preparation), the participant is not
using a contraceptive method consistently; the stages vary on their degree of intention to
initiate use (Precontemplation - no intention to start within six months; Contemplation -
thinking about starting within six months; Preparation - planning to start in next 30 days). In
the two advanced stages of change (Action and Maintenance) the participant is using a
contraceptive method consistently (Action: < 6 months; Maintenance > 6 months). Such
stage definitions are consistent with prior transtheoretical model research [10, 15-17]. We
attempted to contact participants by telephone at 6 and 18 months post-baseline to assess
recent sexual history, contraceptive use, and attitudes regarding dual method use, and to
determine if participants experienced any clinical outcomes including incident STI and/or
unplanned pregnancy. At 12 and 24 months after baseline, participants returned for follow-
up examinations, including STI and pregnancy tests, and follow-up surveys.
The primary outcome of this trial was self-reported initiation of dual methods of
contraception. Any of the following were considered acceptable dual method use: (1) use of
hormonal contraception plus a barrier method; (2) male condoms plus female condoms; (3)
condoms plus spermicide; (4) intrauterine device or sterilization plus a barrier method. Dual
method use was classified from the number of follow-up interviews (at 6, 12, 18, or 24
months) where dual method use was reported as: never initiated dual method use, initiated
use (single follow-up) or sustained use (2 or more follow-ups). Median days of dual method
use were estimated from the start of dual method use to either the end of dual method use or
censoring.
Categorical variables were evaluated using the chi-square or Fisher’s exact test as
appropriate. Continuous variables were evaluated using a Student’s t-test. Median days of
dual method use were compared using a median test. Since our outcome variable had three
categories, multinomial logistic regression models were conducted. Multinomial logistic
regression models can handle outcomes that are polytomous, i.e. more than 2 categories, in
one run, with one category specified as the base outcome. Here in our analysis, with no
initiation of dual method use as the base outcome, crude and adjusted relative risks were
estimated for initiated and sustained dual method use. Crude means that there was single
covariate in the regression model, while the adjusted means that some other covariates were
adjusted for in the regression models. An adjusted model was used to control for possible
confounding between intervention, other covariates, and adherence.
There was significant missing data in the outcome – only 46% of participants had
information on dual method use for all four follow-up time points. Our primary data analysis
assumed that missing observations were equal to zero (or no dual method use; intent-to-treat
analysis). Because this assumption could have biased the result, we completed three
additional analyses to determine the robustness of the current findings: 1) complete case
only (N=211); 2) last value carried forward (LVCF); and 3) next observation carried back
(NOCB). For both the LVCF and NOCB approaches, missing observations were replaced by
either the last or next complete observation. Each of these approaches provided estimates of
relative risks similar to those of the primary data analysis, indicating that our findings were
robust and not significantly impacted by bias. All analyses were performed using Stata 11
(StataCorp, College Station. Texas).
3. Results
Between October 1999 and October 2003, 542 women were enrolled in Project PROTECT
and randomized to the individualized intervention or enhanced standard care groups. The
demographic and reproductive data of our population were presented in our original report
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[9,12]. Briefly, the median age of the population was 22 years, 26% were black, 17% were
Hispanic, 25% had less than a high school education, and 48% were smokers. Four hundred
sixty-three (85%) of the 542 original participants had at least one follow-up interview,
forming the sample for this secondary analysis. Table 1 contains the demographic and
reproductive characteristics of these participants.
Approximately one-third of participants (150/463 = 32.4%) initiated dual method use during
24 months of observation. In our original analysis, the intervention group was associated
with increased initiation of dual method use (HRRadj = 1.70 95% CI 1.09, 2.66), after
controlling for imbalances in the randomization groups [14]. Other predictors of initiation of
dual-method use included educational level, substance use, and hormonal contraceptive use
or condom use at baseline. There were no differences between the 2 groups in terms of
biological outcomes (unintended pregnancies or incident STIs (35% intervention v. 34%
control; HRRadj 1.08 (95% CI 0.81, 1.44)). However, women who reported dual-method use
on two or more follow-up questionnaires had a significantly reduced risk of unintended
pregnancy compared to women who reported dual use less than two times (HRRadj 0.36,
95% CI, 0.15, 0.91) [14].
Of the total sample of 463 women with available follow-up information, only 9.3% (43/463)
reported dual method use on 2 or more follow-up visits. This is only 28.7% (43/150) of
women who initiated dual method use. However, due to missing data, the 9.3% may be an
underestimate of the rate of dual method use at 2 or more follow-up visits. Even with
imputing missing data, the intervention failed to promote adherence to dual methods; more
than three quarters of women (63/82 = 77%) who initiated dual method use did not adhere to
consistent and sustained use.
We assessed the number of interviews in which dual method use was reported. In our
bivariate analysis, level of education, no contraception use at baseline, substance abuse, and
advanced contraceptive stage of change (action or maintenance) were significantly
associated with two or more follow-up visits where dual method use was reported. These
findings persisted in our multivariable analysis after adjusting for confounding factors such
as education, substance use, contraceptive use at baseline, treatment group and stages of
change (Table 2). Education (2-year degree or more: RR = 4.42; 95% CI 1.19, 16.42),
substance abuse (RRadj=0.49; 95% confidence interval (CI) 0.24, 0.97), no contraception at
baseline (RRadj = 0.32; 95% CI 0.11, 0.92), and advanced contraceptive stage of change (RR
= 5.04; 95% CI 1.09, 23.4) remained significant in the multivariable model. Age, race,
smoking status, history of unintended pregnancy, male condom use at baseline, lifetime
number of sexual partners, number of sexual partners in the past month, sex after drinking
alcohol, and forced sex in the past year were not significant predictors of dual contraceptive
method initiation.
In our multinomial regression analysis, four characteristics were noted to be associated with
adherence to dual method use: 1) level of education increased adherence; 2) no
contraceptive use at baseline decreased adherence; 3) substance abuse decreased adherence;
and 4) advanced stage of change (i.e., action or maintenance) increased adherence. These
associations remained in several models where we imputed missing data, regardless of
method chosen for imputation. Analysis of the total dataset (N=463) and an analysis of the
participants with complete information at all four time-points (N=211) found similar
relationships.
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4. Discussion
We found that the tailored, individualized intervention based on the transtheoretical model
of behavior change resulted in an increase in initiation of dual-method contraception use, but
no change in STI incidence or number of unplanned pregnancies compared to enhanced
standard care counseling. This study is unique in analyzing the factors related to non-
adherence to dual methods. We noted that certain demographic, reproductive, and
behavioral characteristics were associated with failure to adhere to consistent dual-method
use: lower educational level, no previous contraceptive use, substance use, and less
advanced stage of change.
Other investigators have demonstrated that condoms must be used consistently and correctly
to prevent STIs [18-20]. Self-reports of condom use are unreliable. Thus, it is no surprise
that we did not see a reduction of the biological outcomes of incident STI and unintended
pregnancy given the level of adherence. Less than 10% of the cohort reported consistent
dual method use. Participants who reported adherence to dual-method use had the lowest
rates of STIs and unintended pregnancies at 24 months [14].
Little is known, however, about factors contributing to initiation of dual-method
contraception and to continued use. Whether educational level improves adherence to
recommended medical regimens is unclear. Several studies have failed to show an
association between education and adherence [21,22], while others have shown an
association [23]. Lower educational level has been correlated with poor adherence to use of
contraceptives, and by extension poor adherence to dual-methods of contraception [23]. Our
study shows a significant relationship between lower educational level and non-adherence to
dual method use. Without consistent use, dual contraceptive method use will not
substantially affect the incidence of STIs or unplanned pregnancy.
Interestingly, although substance use was negatively associated with initiation of dual-
method contraception and adherence to dual method use, sex after drinking alcohol and
smoking status were not associated with initiation or adherence. Additional research is
needed to elucidate the relationship between the context of substance use and dual-method
contraception initiation and continuation.
Lack of prior contraceptive use was similarly correlated with poor adherence to dual-method
contraception. Alternately, more advanced baseline contraceptive stage of change, action or
maintenance, significantly predicted initiation and adherence to dual method use. Those who
were already using contraception at baseline were more likely to maintain dual method use
compared to those who were not. Patients who previously used either oral contraceptives or
condoms were more likely to use dual contraceptive methods consistently. Past experience
helped maintain the repetition and routine necessary for effective use of contraception. In
addition, the hurdle to initiate and maintain the use of two methods is lower for women who
are already successfully using one of these methods.
In the transtheoretical model, action and maintenance stages reflect that the participant was
already using one contraceptive method consistently [10,15,16]. It is not surprising that
these patients were able to initiate and adhere to dual method contraceptive use. Dual
method use can also be viewed as multiple behavior change. In contrast to other studies that
found comparable rates of change in smokers changing one versus more than one behavior
at a time [24], we found that those who had already adopted one behavior (use of one
contraceptive method) were more likely to adopt and maintain dual method use. Establishing
a women’s stage of change for contraceptive use may assist clinicians to identify who is
more likely to adhere to the recommendation of consistent dual method use.
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Often, failure to initiate and adhere to consistent dual method use was not due to the
patient’s inability to adhere to dual-methods, but their partner’s unwillingness to use
condoms. In a previous report, we found that male’s unwillingness to use condoms and
young age combined with low condom self-efficacy score were associated with unprotected
intercourse [25]. In these cases, education for male partners, either individually or in couple-
oriented education, may help increase adherence to male condoms. Furthermore, other
female-controlled barrier methods (e.g., diaphragm, sponge, or cap) could be offered to
women who cannot successfully negotiate condom use with their male partner. However,
studies demonstrating the effectiveness of female-controlled barrier methods for STI
prevention are lacking [26,27].
The strengths of this study include prospective assessment of dual method use over a 24-
month period, sample size, and the diverse cohort of women at high-risk for unintended
pregnancy and STIs. As a secondary analysis we were limited to available data and,
therefore lacked information on relationship status and characteristics. Wilson and Koo [28]
examined contraceptive use among low-income women and found a higher probability of
dual method use among non-cohabitating women who reported emotionally supportive
relationships with their partners and among those who sought to avoid pregnancy. Duration
of relationship was not related to dual method use.
Limited patient exposure to the individualized intervention was one constraint of this study.
There were no “booster” interventions or reminders beyond the third month. Increasing the
number of intervention sessions and providing more information about contraceptive
methods and dual methods over time may lead to even greater initiation and continuation of
dual method contraceptive use. Similarly, additional interventions targeting or tailoring to
those with lower levels of education and those with limited or no experience with
contraceptive use could enhance the efficacy of this intervention approach. With the
increased use of long-acting contraceptive methods such as intrauterine devices and
implants, future studies should assess interventions that couple these highly effective
methods at pregnancy prevention with barrier methods for STI prevention. A recent study
has shown that women using long-acting methods use condoms less frequently than women
using oral contraceptives [8]. Thus, more emphasis on dual methods will be necessary.
In conclusion, many experts have suggested that dual method contraceptive use is the
optimal strategy for STI and unplanned pregnancy prevention [6,7]. However, few
controlled interventions have demonstrated initiation and adherence to dual method use. A
significant limitation to many intervention studies is the reliance on self-report of condom
use. Validation of condom use using markers such as the Y-chromosome (Yc), may be
helpful to validate reported condom use [29]. Future interventions that promote dual method
contraception will have to demonstrate initiation and adherence to see a reduction in the
biological outcomes of STIs and unplanned pregnancies. If effective, these interventions
have the potential to have a lasting impact on both individuals and society.
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Table 2
Crude and adjusted multinomial regression models for initiated or sustained dual methods use compared to no
dual method use (referent)
Crude RF (95% CI) Adjusted* RR (95% CI)
Initiated Sustained Initiated Sustained
Age, years
 <20 Ref Ref Ref Ref
 20-24 0.97[0.58-1.60] 1.08[0.51-2.29] 0.69[0.39-1.21] 0.61[0.26-1.45]
 25+ 0.95[0.50-1.81] 1.18[0.47-2.96] 0.80[0.39-1.61] 0.77[0.27-2.20]
Race/ethnicity
 White, non-Hispanic Ref Ref Ref Ref
 Black, non-Hispanic 0.77[0.44-1.33] 0.82[0.38-1.74] 0.81[0.45-1.45] 0.81[0.33-1.95]
 Hispanic 0.92[0.50-1.69] 0.41[0.14-1.25] 0.98[0.51-1.91] 0.35[0.11-1.14]
 Other 0.83[0.41-1.69] 0.72[0.25-2.01] 0.98[0.46-2.07] 0.84[0.28-2.51]
Education
 Less than high school Ref Ref Ref Ref
 High school/GED 1.33[0.72-2.46] 4.68[1.34-6.34] 1.20[0.65-2.24] 4.26[1.15-15.81]
 2 year degree or more 2.12[1.17-3.82] 5.81[1.67-0.15] 1.76[0.96-3.23] 4.42[1.19-16.42]
Current Smoker
 No Ref Ref Ref Ref
 Yes 0.83[0.53-1.29] 0.73[0.38-1.40] 1.11[0.67-1.83] 1.24[0.59-2.61]
Substance use
 No Ref Ref Ref Ref
 Yes 0.72[0.46-1.13] 0.50[0.26-0.94] 0.66[0.41-1.05] 0.49[0.24-0.97]
History of STI
 No Ref Ref Ref Ref
 Yes 0.70[0.45-1.10] 0.60[0.31-1.16] 0.76[0.47-1.24] 0.74[0.34-1.60]
History of unintended
pregnancy
 No Ref Ref Ref Ref
 Yes 1.06[0.68-1.65] 0.68[0.35-1.30] 1.19[0.75-1.90] 0.62[0.30-1.29]
Contraceptive use at baseline
 Yes Ref Ref Ref Ref
 No 0.59[0.36-0.95] 0.20[0.08-0.52] 0.63[0.35-1.15] 0.32[0.11-0.92]
Male condom at baseline
 No Ref Ref Ref Ref
 Yes 0.86[0.52-1.41] 1.17[0.59-2.31] 0.58[0.31-1.10] 0.80[0.38-1.69]
Lifetime number of sexual
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Crude RF (95% CI) Adjusted* RR (95% CI)
Initiated Sustained Initiated Sustained
partners
 1-2 Ref Ref Ref Ref
 3-5 0.96[0.48-1.90] 1.70[0.60-4.80] 0.90[0.45-1.78] 1.48[0.50-4.40]
 6-10 1.08[0.53-2.21] 0.81[0.24-2.70] 1.02[0.48-2.19] 0.92[0.26-3.18]
 11 or more 0.64[0.31-1.34] 0.89[0.29-2.78] 0.68[0.32-1.43] 0.93[0.28-3.09]
No. sexual partners in past
month
 0 Ref Ref Ref Ref
 1 1.51[0.76-2.98] 2.49[0.73-8.45] 1.54[0.75-3.16] 2.23[0.64-7.71]
 2 or more 1.49[0.63-3.53] 2.78[0.67-11.4] 1.72[0.68-4.33] 3.57[0.84-15.2]
Sex after drinking
 Never Ref Ref Ref Ref
 1 to 2 times 0.75[0.43-1.28] 0.95[0.47-1.95] 0.94[0.54-1.66] 1.35[0.56-3.25]
 3 or more times 1.76[1.03-3.02] 0.88[0.35-2.16] 2.25[1.23-4.09] 1.21[0.46-3.19]
Forced to have sex in past
year
 No Ref Ref Ref Ref
 Yes 0.73[0.34-1.58] 0.38[0.09-1.66] 0.95[0.41-2.23] 0.63[0.13-3.03]
Treatment group
 Control Ref Ref Ref Ref
 Intervention 1.56[1.00-2.43] 0.86[0.45-1.63] 1.52[0.96-2.41] 0.89[0.45-1.75]
Stages of change
 Pre-contemplation /
contemplation Ref Ref Ref Ref
 Preparation 1.13[0.58-2.20] 2.80[0.58-13.6] 1.49[0.72-3.07] 3.87[0.80-18.7]
 Action/maintenance 1.54[0.84-2.81] 7.50[1.74-32.3] 1.41[0.72-2.77] 5.04[1.09-23.4]
*Adjusted for treatment group, education, substance use, contraceptive use at baseline, and stages of change
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